$TSNDF

Short Interest in TerrAscend Corp. (OTCMKTS:TSNDF) Declines By 47.2%

TerrAscend Corp. (OTCMKTS:TSNDF) saw short interest fall 47.2% in May, to 692,277 shares as of May 15 from 1,311,616 on April 30, according to the report. Short interest equals 0.3% of shares; days to cover is 1.0. The stock traded at $0.72. In its May 7 quarter, EPS was -$0.03 vs -$0.02 expected on revenue of $65.54M.

Original reporting
Published Jun 1, 2026, 7:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 8:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Short Interest in TerrAscend Corp. (OTCMKTS:TSNDF) Declines By 47.2% — source image
Decision brief

The 30-second read

$TSNDFBullishMed
01

Why it matters

A 47.2% reduction in short interest suggests fewer shares are being bet against, potentially lowering downside pressure from short-cover dynamics; however, the stock remains loss-making and the update is positioning-only.

02

Market read

Traders may use the short-interest drop and 1.0 days-to-cover as a near-term positioning input, but it is not a fundamental re-rating catalyst by itself.

03

What to watch

The article cites OTC trading/volume and prior earnings miss; without new operational guidance, the move may fade quickly.

Relevance 7/10Novelty 6/10Timing: Positioning update for May short interest (as of May 15)

Background

The piece reports a month-over-month change in TerrAscend’s short interest and summarizes recent earnings and analyst rating context.

Company-level read

Ticker impact

$TSNDFBullishMedium confidence
Context

TerrAscend’s short interest fell 47.2% in May, with days-to-cover at 1.0, signaling reduced near-term short pressure.

Expected impact

Mild upside bias near term; magnitude likely limited given OTC liquidity and small short float (0.3%).

Evidence & confidence

The article provides a concrete positioning datapoint (short interest change, days-to-cover) but no new fundamental catalyst beyond prior earnings/analyst notes.

Market effects

Cannabis names can see sentiment swings from positioning metrics; reduced shorting may modestly improve read-through for similarly distressed names.

Primarily affects North American cannabis microcap sentiment; limited broader regional spillover.

Low—single-company OTC positioning update with no cross-market catalyst.

Counterpoint

Short interest can decline because shorts exit for reasons unrelated to fundamentals (e.g., liquidity/borrow constraints), so price may not follow.

Key entities

  • TerrAscend Corp.

    Subject of the short-interest decline report; OTC ticker TSNDF.

  • Zacks Research

    Upgraded TerrAscend from strong sell to hold (not a new catalyst in this article’s timeframe).

Related articles

$TSNDFMedAI 8/10

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

TerrAscend Corp. said it filed notice for a special shareholder meeting on Aug. 24, 2026 to vote on a share consolidation, with a June 30, 2026 record date. The company said the consolidation is intended to help meet U.S. stock exchange share-price criteria and support a potential uplisting. Details, including the ratio, will be in an SEC/SEDAR+ circular.

$MRNAMedAI 8/10

Why Is Moderna Stock Down Today?

Moderna's stock fell Thursday, reducing its market cap by $18B after a record surge following positive cancer vaccine trial results. Co-founders and CEO saw significant net worth changes. Analysts view the trial as critical for Moderna's stock. The company's revenue is $145M with a net loss of $782M in the latest quarter, per the company.

$LMTMed

Why Did Lockheed Martin Stock Drop Today?

Lockheed Martin (LMT) stock fell 2.7% despite a positive announcement. The company demonstrated a partnership with Saildrone, using a Saildrone Surveyor to fire Lockheed-built missiles. The test also showcased threat-identification and electronic warfare systems. Lockheed aims to expand this collaboration, potentially increasing its market for weapons systems. The stock's decline contradicts the positive news.

$WMTHighAI 8/10

TSX Takes Bruises Early Afternoon

The TSX fell 104.72 points to 36,297.07 on Thursday, following global market declines. Walmart shares dropped 9% after missing sales forecasts and lowering earnings guidance. U.S. stocks also declined, with the Dow, S&P 500, and Nasdaq all down. Bond yields rose, and oil prices increased due to geopolitical tensions.

$MRNAMedAI 9/10

Moderna Stock Plunges 25%—Wiping Out $18 Billion After Historic Cancer Vaccine Breakthrough

Moderna's stock fell 25% on Thursday, reducing its market value by $18 billion, after a 176% surge the previous day. The initial rise followed positive trial results for its cancer vaccine, developed with Merck's Keytruda. Analysts praised the results but noted further testing is needed. Moderna's market cap is now $51.5 billion. According to Bank of America, the results diversify Moderna's portfolio beyond infectious diseases.